Decreased levels of sphingosine, a natural antimicrobial agent, may be associated with vulnerability of the stratum corneum from patients with atopic dermatitis to colonization by staphylococcus aureus

Journal of Investigative Dermatology

Volumn 119, Issue 2, 2002, Pages 433-439

  Arikawa, Junko ^a   Ishibashi, Mutsumi ^a   Kawashima, Makoto ^a   Takagi, Yutaka ^b   Ichikawa, Yoshiaki ^b   Imokawa, Genji ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b Kao Biological Science Laboratories   (Japan)

Author keywords

Ceramidases; Ceramide; Glucosylceramide deacylase; Sphingomyelin deacylase

Indexed keywords

ACYLSPHINGOSINE DEACYLASE; CERAMIDE; SPHINGOSINE;

ADOLESCENT; ADULT; ANTIMICROBIAL ACTIVITY; ARTICLE; ATOPIC DERMATITIS; BACTERIAL COLONIZATION; BACTERIAL COUNT; BACTERIAL IMMUNITY; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME SUBSTRATE; HUMAN; HUMAN TISSUE; PH; PRIORITY JOURNAL; REGULATORY MECHANISM; SKIN; STAPHYLOCOCCUS AUREUS; STRATUM CORNEUM; TISSUE LEVEL;

EID: 0036036354     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2002.01846.x     Document Type: Article

References (27)

1. Quantitative analysis of stratum corneum lipids in xerosis and asteatotic eczema
2. Comparison of the severity of atopic dermatitis lesions and the density of Staphylococcus aureus on the lesions after antistaphylococcal treatment
3. Inhibition of microbial adherence by sphingosine
4. Antimicrobial activity of sphingosines
5. Sphingosines: Antimicrobial barriers of the skin
6. Topical sphingolipids in antisepsis and antifungal therapy
7. The expression of the gene encoding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders
8. The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6
9. Diagnostic features of atopic dermatitis
10. High-expression of sphingomyelin deacylase is an important determinant of ceramide deficiency leading to barrier disruption in atopic dermatitis
11. A peptide antibiotic from human skin
12. The skin of atopic dermatitis patients contains a novel enzyme, glucosylceramide sphingomyelin deacylase, which cleaves the N-acyl linkage of sphingomyelin and glucosylceramide
13. Antimicrobial peptides as mediators of epithelial host defence
14. Reduced secretion of IgA to skin surface of patients with atopic dermatitis
15. Decreased level of ceramides in stratum corneum of atopic dermatitis: An etiologic factor in atopic dry skin?
16. Skin moisturizers. Development and clinical use of ceramides
17. A novel enzyme that cleaves the N-acyl linkage of ceramides in various glycosphingolipids as well as sphingomyelin to produce their lyso forms
18. Analysis of β-glucocerebrosidase and ceramidase activities in atopic and aged dry skin
19. Abnormal expression of sphingomyelin acylase in atopic dermatitis: An etiologic factor for ceramide deficiency?
20. Ceramidase activity in bacterial skin flora as a possible cause of ceramide deficiency in atopic dermatitis
21. Quantification of free sphingosine in cultured cells by acylation with radioactive acetic anhydride
22. Purification and characterization of a novel ceramidase from Pseudomonaus aeruginosa
23. Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with 1-lysine
24. Effect of lactic acid isomers on keratinocyte ceramide synthesis, stratum corneum lipid levels and stratum corneum barrier function
25. Epidermal sphingomyelins are precursors for selected stratum corneum ceramides
26. Purification and biochemical characterization of membrane-bound epidermal ceramidases from guinea pig skin
27. Beta-defensins: Linking innate and adaptive immunity through dendritic and T cell CCR6